Konopleva M, DiNardo C, Bhagat T, Baran N, Lodi A, Saxena K, Cai T, Su X, Skwarska A, Guerra V, Kuruvilla V, Konoplev S, Gordon-Mitchell S, Pradhan K, Aluri S, Collins M, Sweeney S, Busquet J, Rathore A, Deng Q, Green M, Grant S, Demo S, Choudhary G, Sahu S, Agarwal B, Spodek M, Thiruthuvanathan V, Will B, Steidl U, Tippett G, Burger J, Borthakur G , Jabbour E, Pemmaraju N, Kadia T, Komblau S, Daver N, Naqvi K, Short N, Garcia-Manero G, Tiziani S, Verma A
Peptides like CJC-1295, Ipamorelin, and BPC-157 can help address the muscle loss and metabolic decline of perimenopause by: Enhancing growth hormone release (which naturally declines with age) Improving muscle protein synthesis and recovery Enhancing fat metabolism Improving sleep quality Supporting tissue repair and metabolic function We often use peptide therapy in combination with hormone optimization and targeted strength training to actively improve body composition rather than just preventing further decline
Freezing reconstituted peptides may extend stability though repeated freeze-thaw cycles should be avoided
PINK1 activates through autophosphorylation and phosphorylates serine residues on adjacent ubiquitin molecules
